Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
11.32
-0.12 (-1.05%)
Sep 9, 2025, 4:00 PM - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $1.20 billion as of September 10, 2025. Its market cap has decreased by -25.38% in one year.
Market Cap
1.20B
Enterprise Value
407.80M
1-Year Change
-25.38%
Ranking
Category
Stock Price
$11.32
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $1.20B, an increase of 71.01%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1.22B | -10.64% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |